pharmaceuticals

Could These 6 Marijuana Stocks Recapture Much of Their Stock Losses?
Marijuana stocks have suffered a terrible beating in the past year or so. Here's a look at six former high-flyers and their prospects for a recovery.
Paul Ausick
4 hours ago

Why Pfizer's Stock Could Rise 60% or More
Pfizer is among the current frontrunners for a COVID-19 vaccine, so why is its stock down 13% year to date? And why does one independent research firm say this stock could run much higher?
Chris Lange
2 days ago

Why This Analyst Sees Big Upside in COVID-19 Immunotherapy Study
After Corvus Pharmaceuticals announced that it would initiate an early-stage immunotherapy study in patients with COVID-19, Wedush sees this stock running much higher.
Chris Lange
2 days ago

Operation Warp Speed Against COVID-19 Ramps Up With Novavax and Regeneron
Novavax and Regeneron Pharmaceuticals each made solid progress on Tuesday after each company received a sizable capital injection from the U.S. government’s Operation Warp Speed program.
Chris Lange
3 days ago
Last Updated: 3 days ago

5 Speculative COVID-19 Stocks That Could Still Surge
24/7 Wall Street has picked out a few of the best and brightest coronavirus stocks that could still see a big push as 2020 continues.
Chris Lange
3 days ago

5 FDA COVID-19 Decisions in July Could Make or Break Stocks
Here is a look of a few of the biggest clinical trial and FDA updates to watch for in July 2020.
Chris Lange
7 days ago

Meet the New Frontrunners in the Race for a COVID-19 Vaccine
Pfizer and BioNTech have been collaborating to produce a messenger RNA based vaccine for the past few months, and this work is yielding promising results.
Chris Lange
9 days ago

Is OptiNose the Next Big Coronavirus Stock?
OptiNose shares popped on Tuesday after the company announced that it is making a move toward fighting COVID-19 with its tech.
Chris Lange
10 days ago

What This FDA Update Means for Intercept Pharma
Intercept Pharmaceuticals stock was crushed early on Monday after the firm received an update from the FDA in regards to its treatment of fibrosis due to nonalcoholoic steatohepatitis.
Chris Lange
11 days ago

Royalty Pharma Enters the Market With a Bang
Royalty Pharma shares entered the market with a bang on Tuesday.
Chris Lange
24 days ago

Why Some Analysts Remain Bullish on Amarin Stock
Is it time to buy Amarin? The biopharmaceutical company just announced a new study showing its drug Vascepa can significantly reduce cardiovascular risk in people with diabetes.
Carl Sullivan
24 days ago

Meet Sanofi's Big New Investment Into a COVID-19 Vaccine
Sanofi's announcement that it would be investing in a COVID-19 vaccine production site in France gave shares a boost early Tuesday.
Chris Lange
24 days ago

Canaccord Genuity's Top Biopharma Catalysts for the Rest of 2020
Canaccord Genuity recently released a report detailing some of the biggest biotech catalysts coming out over these next six months.
Chris Lange
25 days ago

Johnson & Johnson Accelerates Its COVID-19 Vaccine Hopes
Johnson & Johnson has announced that it will accelerate initiation of its early stage first-in-human clinical trial for the treatment of COVID-19. Shares got a mild boost on Wednesday from the news.
Chris Lange
1 month ago
Last Updated: 1 month ago

Amarin Stock Is in a Holding Pattern
Amarin is on hold as generic rivals seek to copy its potential blockbuster Vascepa.
Carl Sullivan
1 month ago
Last Updated: 1 month ago